Evidence map›Paper›PMID 39839075›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

Dynamic neurocognitive adaptation in aging: Development and validation of a new scale.

Filippo Cieri, Giulia Di Francesco, Chad Lee Cross, Andrew Bender, Jessica Zoe Kirkland Caldwell

Registry-linked trialAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07533084 (Italian Validation of the Dynamic Neurocognitive Adaptation), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07533084 not yet recruitingnot on this map

Italian Validation of the Dynamic Neurocognitive Adaptation (dNA) Scale and Its Correlation With Neurocognitive Variables

Typeobservational_patient_registrySponsorNeuromed IRCCSRan2026 to 2027Enrolled265ConditionsActive Aging Individuals Aged 65 and Over, Aging, Mild Cognitive Impairment (MCI), Dementia
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Filippo CieriDepartment of Neurology Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada USA.
Giulia Di FrancescoHematology Unit, Department of Oncology-Hematology Pescara Hospital Pescara Italy.
Chad Lee CrossDepartment of Neurology Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada USA.
Andrew BenderDepartment of Neurology Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada USA.
Jessica Zoe Kirkland CaldwellDepartment of Neurology Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada USA.

Funding

Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - ResubmissionP20GM109025 · NIGMS · CLEVELAND CLINIC FOUNDATION · PI JESSICA KIRKLAND CALDWELL · 2015 to 2026
$22.8M
NVEDARC Clinical CoreP20AG068053 · NIA · CLEVELAND CLINIC FOUNDATION · PI FOX, ROBERT J. · 2020 to 2022
$3.3M
Dark GPCR signaling underlying the Microbiome-Gut-Brain Axis for Alzheimer's Disease and Related DementiaRF1NS133812 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI BROWN, JONATHAN MARK, CHENG, FEIXIONG · 2023 to 2023
$2.3M
Interactions of Sex and Gender Factors in Risk for Alzheimers Disease: Links Between Stress, Neural Activity, Inflammation, and MemoryR01AG074392 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI KIRKLAND CALDWELL, JESSICA · 2021 to 2024
$1.8M
NIA NIH HHS P20 AG068053NIA NIH HHS R01 AG074392NIGMS NIH HHS P20 GM109025NINDS NIH HHS RF1 NS133812
6 · The paper itself

Abstract

introductionForty-five percent of Alzheimer's disease (AD) cases may have been preventable through protective factors. Reserve, resilience, and resistance share common neurocognitive adaptive processes, acting through protective mechanisms. In this article we propose the development and validation of a new scale, called dynamic Neurocognitive Adaptation, developed in this direction.

methodsWe included 815 participants (50% women; 65+ years inclusive of age), divided into two subsamples for exploratory and confirmatory factor analysis. Our initial scale was composed of 30 items, investigating seven dimensions, explored by a 5-point Likert scale reflecting the frequency of activities, for seven time windows.

resultsOur final scale had 20 items divided among four dimensions: physical, cognitive, creative, and social. There were no issues related to multi-collinearity or non-collinearity. Kaiser-Meyer-Olkin (KMO) = 0.80 and Bartlett's test of sphericity indicated all values ≤0.01; Cronbach's alpha = 0.83. DISCUSSION: We have validated a reliable, novel, easy to complete, and comprehensive scale to assess lifetime behaviors, which can be applied in research on AD risk reduction, mild cognitive impairment, and in clinical practice. Highlights: Reserve, resistance, and resilience share similar adaptive mechanisms.Dynamic Neurocognitive Adaptation is a new scale to assess lifetime protective factors.Dynamic Neurocognitive Adaptation is a reliable, novel, and easy to complete scale.This approach can characterize specific life stages that are ripe for risk-reduction interventions.Our scale can be used to personalize health recommendations in aging.

Indexed as

activitiesadaptationdynamicneurocognitivepreventionreserveresilienceresistancevalidationwell‐being

Identifiers

PMID39839075
PMCPMC11746070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.